Clinical trials are the backbone of evidence-based medicine—but too often, they struggle with inefficiency, poor recruitment, and avoidable design flaws. In this episode of Clinical Trial Files, we’re joined by Shaun Treweek, Professor of Health Services Research and a leading voice in clinical trial methodology.

Shaun shares his perspective on why so many trials fail to recruit as planned, what the research community gets wrong about trial design, and how embedded studies and methodological research can dramatically improve how trials are run. Drawing from decades of experience across academia, global research collaborations, and methodological innovation, he challenges conventional thinking and advocates for a more evidence-informed approach to doing research itself.

We explore practical ways to make trials more efficient, more ethical, and more likely to deliver meaningful results—while asking a fundamental question: Why don’t we apply the same rigor to how we design trials as we do to the interventions we test?

Whether you’re a researcher, coordinator, sponsor, or policymaker, this episode offers a thoughtful, grounded look at how we can stop repeating the same mistakes and start building better trials from the ground up.

In this episode of Clinical Trial Files, we’re joined by Akanksha Jain, a clinical research quality and data professional with deep expertise spanning biostatistics, data management, risk-based quality management (RBQM), and trial oversight.

Akanksha shares her career journey from a strong foundation in statistics into clinical research, offering a unique perspective on how data, quality, and operational decision-making intersect across the clinical trial lifecycle. She explains why quality cannot be an afterthought—and how embedding risk-based thinking early in study design leads to stronger outcomes, better compliance, and fewer downstream issues.

The conversation explores practical applications of RBQM, centralized monitoring, and data-driven oversight, along with common misconceptions about quality roles in clinical trials. Akanksha also discusses the evolving expectations under ICH E6 (R3), including proactive risk identification, cross-functional collaboration, and the growing importance of analytics in sponsor and CRO decision-making.

Listeners will gain insight into how quality professionals can move from reactive issue management to strategic partners within clinical development teams—and how early-career professionals can build the skills needed to thrive in an increasingly data-centric research environment.

This episode is a must-listen for clinical research professionals interested in quality management, data strategy, monitoring innovation, and the future of risk-based oversight.

In this episode of Clinical Trial Files, we sit down with Karen Cloete, founder of TASK Research Academy, to explore how clinical research training can, and must, evolve beyond silos and checklists.

With over 17 years of experience across clinical operations, monitoring, audits, compliance, and sponsor oversight, Karen shares her unconventional journey into clinical trials and how seeing the industry from every angle inspired her to rethink how professionals are trained. From CRA to site leader to sponsor-side expert, Karen explains why understanding the entire clinical trial lifecycle is essential for quality, compliance, and career growth.

The conversation dives into real-world challenges in global training, including language barriers, cultural context, and regulatory complexity, and how animation, simulation, and scenario-based learning can make training more inclusive, practical, and engaging. Karen also discusses TASK Research Academy’s innovative approach to experiential learning, internships, and workforce development, helping research-naïve professionals successfully enter the field.

We also unpack key updates from ICH E6 (R3), including service provider oversight, data governance, sponsor responsibilities, and decentralized trial considerations—what they mean in practice and where sites should focus now.

Whether you’re a CRA, coordinator, investigator, sponsor, or educator, this episode highlights why seeing the “big picture” in clinical research isn’t optional—it’s foundational.